Italy experienced one of the world's deadliest COVID-19 outbreaks and healthcare systems had to instantly reorganise activity. The Italian Radiation Oncology Departments adapted numerous solutions to minimize the disruptions. Information technologies, treatment prioritization and implementation of hypofractionation and protection procedures allowed balancing between cancer patient care and patient/healthcare workers safety.
COVID-19 outbreak and cancer radiotherapy disruption in Italy: Survey endorsed by the Italian Association of Radiotherapy and Clinical Oncology (AIRO) / Jereczek-Fossa, B. A.; Pepa, M.; Marvaso, G.; Bruni, A.; Buglione di Monale e Bastia, M.; Catalano, G.; Filippi, A. R.; Franco, P.; Gambacorta, M. A.; Genovesi, D.; Iati, G.; Magli, A.; Marafioti, L.; Meattini, I.; Merlotti, A.; Mignogna, M.; Musio, D.; Pacelli, R.; Pergolizzi, S.; Tombolini, V.; Trovo, M.; Ricardi, U.; Magrini, S. M.; Corvo, R.; Donato, V.. - In: RADIOTHERAPY AND ONCOLOGY. - ISSN 0167-8140. - 149:(2020), pp. 89-93. [10.1016/j.radonc.2020.04.061]
COVID-19 outbreak and cancer radiotherapy disruption in Italy: Survey endorsed by the Italian Association of Radiotherapy and Clinical Oncology (AIRO)
Bruni A.;
2020
Abstract
Italy experienced one of the world's deadliest COVID-19 outbreaks and healthcare systems had to instantly reorganise activity. The Italian Radiation Oncology Departments adapted numerous solutions to minimize the disruptions. Information technologies, treatment prioritization and implementation of hypofractionation and protection procedures allowed balancing between cancer patient care and patient/healthcare workers safety.
| File | Dimensione | Formato | |
|---|---|---|---|
|
main.pdf
Open access
Tipologia:
VOR - Versione pubblicata dall'editore
Licenza:
[IR] unspecified-oa
Dimensione
535.09 kB
Formato
Adobe PDF
|
535.09 kB | Adobe PDF | Visualizza/Apri |
Pubblicazioni consigliate
I metadati presenti in IRIS UNIMORE sono rilasciati con licenza Creative Commons CC0 1.0 Universal, mentre i file delle pubblicazioni sono rilasciati con licenza Attribuzione 4.0 Internazionale (CC BY 4.0), salvo diversa indicazione.
In caso di violazione di copyright, contattare Supporto Iris
